๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Su1539 A Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in Patients With Sphincter of Oddi Dysfunction Type 3

โœ Scribed by Kaplan, Jeremy H.; Zabolotsky, Andrew H.; Kowalski, Thomas E.; Loren, David E.; Korenblit, Jason; Adler, Douglas G.; Eloubeidi, Mohamad a.; Siddiqui, Ali


Book ID
122279835
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
65 KB
Volume
79
Category
Article
ISSN
1097-6779

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Pancreatic duct stent placement prevents
โœ Abdo M. Saad; Evan L. Fogel; Lee McHenry; James L. Watkins; Stuart Sherman; Laur ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 178 KB

Background: Placement of a pancreatic duct (PD) stent reduces post-ERCP pancreatitis rates in high-risk patients. Patients with suspected sphincter of Oddi dysfunction (SOD) who are found to have normal manometry results (SOM) are also at high risk for this complication. Objective: Our purpose was